Department: Research & Development
Location: Boulder, CO (onsite)
At Ambrosia Biosciences, our mission is to develop innovative, orally delivered small-molecule therapies that address the global challenges of obesity and metabolic disorders. Founded in 2024 and headquartered in Boulder, Colorado, we leverage a world-class team of scientists to pioneer next-generation treatments targeting incretins and class B GPCRs. Backed by leading investors, including Merck, BVF Partners, and Boulder Ventures, we are committed to advancing safe, effective, and accessible therapeutics that transform lives worldwide.
As we expand our operations and accelerate our preclinical programs, we seek passionate, driven individuals eager…
Click here to view original post
